Quantitative systems pharmacology and the personalized drug–microbiota–diet axis

Nebert, 2008, From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions, Drug Metab Rev, 40, 187, 10.1080/03602530801952864 Haiser, 2013, Developing a metagenomic view of xenobiotic metabolism, Pharmacol Res: Off J Ital Pharmacol Soc, 69, 21, 10.1016/j.phrs.2012.07.009 Mardinoglu, 2015, The gut microbiota modulates host amino acid and glutathione metabolism in mice, Mol Syst Biol, 11, 834, 10.15252/msb.20156487 Jamei, 2016, Recent advances in development and application of physiologically-based pharmacokinetic (PBPK) models: a transition from academic curiosity to regulatory acceptance, Curr Pharmacol Rep, 2, 161, 10.1007/s40495-016-0059-9 Kitano, 2013 Wilson, 2009, Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring, Proc Natl Acad Sci U. S. A, 106, 14187, 10.1073/pnas.0907721106 Schork, 2015, Personalized medicine: time for one-person trials, Nature, 520, 609, 10.1038/520609a Campbell, 2014, A review of pharmacovigilance, West Indian Med J, 63, 771 Alomar, 2014, Factors affecting the development of adverse drug reactions (Review article), Saudi Pharm J, 22, 83, 10.1016/j.jsps.2013.02.003 Clayton, 2009, Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism, Proc Natl Acad Sci U. S. A, 106, 14728, 10.1073/pnas.0904489106 Drew, 2016, Pharmacogenetics: the right drug for you, Nature, 537, S60, 10.1038/537S60a Nayak, 2016, Mirror, mirror on the wall: which microbiomes will help heal them all?, BMC Med, 14, 72, 10.1186/s12916-016-0622-6 Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing, Nature, 464, 59, 10.1038/nature08821 Falony, 2016, Population-level analysis of gut microbiome variation, Science, 352, 560, 10.1126/science.aad3503 Nicholson, 2012, Host-gut microbiota metabolic interactions, Science, 336, 1262, 10.1126/science.1223813 Maurice, 2013, Xenobiotics shape the physiology and gene expression of the active human gut microbiome, Cell, 152, 39, 10.1016/j.cell.2012.10.052 Klaassen, 2015, Review: mechanisms of how the intestinal microbiota alters the effects of drugs and bile acids, Drug Metab Dispos, 43, 1505, 10.1124/dmd.115.065698 Tralau, 2015, Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology?, Expert Opin Drug Metab Toxicol, 11, 411, 10.1517/17425255.2015.990437 Haiser, 2012, Is it time for a metagenomic basis of therapeutics?, Science, 336, 1253, 10.1126/science.1224396 Spanogiannopoulos, 2016, The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism, Nat Rev, 14, 273 Haiser, 2013, Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta, Science, 341, 295, 10.1126/science.1235872 Haiser, 2014, Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics, Gut Microbes, 5, 233, 10.4161/gmic.27915 Moya, 2016, Functional redundancy-induced stability of gut microbiota subjected to disturbance, Trends Microbiol, 24, 402, 10.1016/j.tim.2016.02.002 Rowland, 2013, Physiologically-based pharmacokinetic (PBPK) modeling and simulations principles, methods, and applications in the pharmaceutical industry, CPT Pharmacomet Syst Pharmacol, 2, e55, 10.1038/psp.2013.29 Nestorov, 2003, Whole body pharmacokinetic models, Clin Pharmacokinet, 42, 883, 10.2165/00003088-200342100-00002 Knight-Schrijver, 2017, The promises of quantitative systems pharmacology modelling for drug development, Comput Struct Biotechnol J, 14, 363, 10.1016/j.csbj.2016.09.002 Kell, 2014, Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery, Drug Discov today, 19, 171, 10.1016/j.drudis.2013.07.014 Upton, 2016, An introduction to physiologically-based pharmacokinetic models, Paediatr Anaesth, 26, 1036, 10.1111/pan.12995 Nestorov, 2007, Whole-body physiologically based pharmacokinetic models, Expert Opin Drug Metab Toxicol, 3, 235, 10.1517/17425255.3.2.235 Jones, 2013, Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development, CPT Pharmacomet Syst Pharmacol, 2, e63, 10.1038/psp.2013.41 Rostami-Hodjegan, 2012, Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology, Clin Pharmacol Ther, 92, 50, 10.1038/clpt.2012.65 Sager, 2015, Physiologically based pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification, Drug Metab Dispos, 43, 1823, 10.1124/dmd.115.065920 Yoshida, 2013, Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models, BMC Syst Biol, 7, S3, 10.1186/1752-0509-7-S3-S3 Guebila, 2016, Model-based dietary optimization for late-stage, levodopa-treated, Parkinson's disease patients, Npj Syst Biol Appl, 2, 16013, 10.1038/npjsba.2016.13 Agoram, 2001, Predicting the impact of physiological and biochemical processes on oral drug bioavailability, Adv Drug Deliv Rev, 50, S41, 10.1016/S0169-409X(01)00179-X Yu, 1998, Characterization of small intestinal transit time distribution in humans, Int J Pharm, 171, 157, 10.1016/S0378-5173(98)00174-4 Price, 2003, Modeling interindividual variation in physiological factors used in PBPK models of humans, Crit Rev Toxicol, 33, 469, 10.1080/10408440390242324 McNally, 2014, PopGen: a virtual human population generator, Toxicology, 315, 70, 10.1016/j.tox.2013.07.009 Strolin Benedetti, 2005, Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations, Expert Opin Drug Metab Toxicol, 1, 447, 10.1517/17425255.1.3.447 Barrett, 2012, Physiologically based pharmacokinetic (PBPK) modeling in children, Clin Pharmacol Ther, 92, 40, 10.1038/clpt.2012.64 Abduljalil, 2012, Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling, Clin Pharmacokinet, 51, 365, 10.2165/11597440-000000000-00000 Young, 1997, Physiological “constants” for PBPK models for pregnancy, J Toxicol Environ Health, 52, 385 Thompson, 2009, Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly, J Toxicol Environ Health B Crit Rev, 12, 1, 10.1080/10937400802545060 Palsson, 2006 Thiele, 2013, A community-driven global reconstruction of human metabolism, Nat Biotechnol, 31, 419, 10.1038/nbt.2488 Agren, 2014, Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling, Mol Syst Biol, 10, 721, 10.1002/msb.145122 Swainston, 2016, Recon 2.2: from reconstruction to model of human metabolism, Metab: Off J Metab Soc, 12, 109 Sahoo, 2015, Modeling the effects of commonly used drugs on human metabolism, FEBS J, 282, 297, 10.1111/febs.13128 Jamshidi, 2006, Systems biology of SNPs, Mol Syst Biol, 2, 38, 10.1038/msb4100077 Sahoo, 2012, A compendium of inborn errors of metabolism mapped onto the human metabolic network, Mol Biosyst, 8, 2545, 10.1039/c2mb25075f Pagliarini, 2016, In silico modeling of liver metabolism in a human disease reveals a key enzyme for histidine and histamine homeostasis, Cell Rep, 15, 2292, 10.1016/j.celrep.2016.05.014 Shaked, 2016, Metabolic network prediction of drug side effects, Cell Syst, 2, 209, 10.1016/j.cels.2016.03.001 Chang, 2010, Drug off-target effects predicted using structural analysis in the context of a metabolic network model, PLoS Comput Biol, 6, 10.1371/journal.pcbi.1000938 Wadehn, 2016, A multiscale, model-based analysis of the multi-tissue interplay underlying blood glucose regulation in diabetes Krauss, 2012, Integrating cellular metabolism into a multiscale whole-body model, PLoS Comput Biol, 8, e1002750, 10.1371/journal.pcbi.1002750 Toroghi, 2016, A multi-scale model of the whole human body based on dynamic parsimonious flux balance analysis, IFAC-PapersOnLine, 49, 937, 10.1016/j.ifacol.2016.07.319 Gille, 2010, HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology, Mol Syst Biol, 6, 411, 10.1038/msb.2010.62 Bordbar, 2011, A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology, BMC Syst Biol, 5, 180, 10.1186/1752-0509-5-180 Sahoo, 2013, Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells, Hum Mol Genet, 22, 2705, 10.1093/hmg/ddt119 Uhlen, 2015, Proteomics. Tissue-based map of the human proteome, Science, 347, 1260419, 10.1126/science.1260419 Aurich, 2016, Computational modeling of human metabolism and its application to systems biomedicine, Methods Mol Biol, 1386, 253, 10.1007/978-1-4939-3283-2_12 Magnusdottir, 2017, Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota, Nat Biotechnol, 35, 81, 10.1038/nbt.3703 Heinken, 2015, Systematic prediction of health-relevant human-microbial co-metabolism through a computational framework, Gut Microbes, 6, 120, 10.1080/19490976.2015.1023494 Klunemann, 2014, Computational tools for modeling xenometabolism of the human gut microbiota, Trends Biotechnol, 32, 157, 10.1016/j.tibtech.2014.01.005 Ravcheev, 2016, Genomic analysis of the human gut microbiome suggests novel enzymes involved in quinone biosynthesis, Front Microbiol, 7, 10.3389/fmicb.2016.00128 Shoaie, 2015, Quantifying diet-induced metabolic changes of the human gut microbiome, Cell metab, 22, 320, 10.1016/j.cmet.2015.07.001 Nogiec, 2013, To supplement or not to supplement: a metabolic network framework for human nutritional supplements, PLoS One, 8, e68751, 10.1371/journal.pone.0068751 Dontchev, 2001, Primal-dual solution perturbations in convex optimization, Set-Valued Anal, 9, 49, 10.1023/A:1011298415881 Fleming, 2012, A variational principle for computing nonequilibrium fluxes and potentials in genome-scale biochemical networks, J Theor Biol, 292, 71, 10.1016/j.jtbi.2011.09.029 Mardsen, 2001, Discrete mechanics and variational integrators, Acta Numer, 10, 357, 10.1017/S096249290100006X Ma, D.Y.L.; Fleming, R.M.T.; Thiele, I.; Palsson, B.O.; Saunders, M.A. (2016). Reliable and efficient solution of genome-scale models of Metabolism and macromolecular Expression. Campbell, 2016, Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses, Pharmacogen J, 17, 21, 10.1038/tpj.2016.58